3,4-dihydroxyphenylacetic acid has been researched along with 2-amino-3-phenylbutanoic acid in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, Y; Ma, J; Yuan, L | 1 |
1 other study(ies) available for 3,4-dihydroxyphenylacetic acid and 2-amino-3-phenylbutanoic acid
| Article | Year |
|---|---|
β-Methylphenylalanine exerts neuroprotective effects in a Parkinson's disease model by protecting against tyrosine hydroxylase depletion.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aminobutyrates; Animals; Cell Survival; Dopamine; Humans; Membrane Potential, Mitochondrial; Molecular Docking Simulation; Neuroprotective Agents; Parkinson Disease; Rats; Reactive Oxygen Species; RNA, Messenger; Rotenone; Tyrosine 3-Monooxygenase | 2020 |